MiR-7-1 potentiated estrogen receptor agonists for functional neuroprotection in VSC4.1 motoneurons

Neuroscience

Volumn 256, Issue , 2014, Pages 322-333

  Chakrabarti, M ^a   Banik, N L ^b   Ray, S K ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Apoptosis; CI; CP 1C; ER agonists; MiR 7 1; VSC4.1 motoneurons

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL L TYPE; CALCIUM IONOPHORE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MICRORNA; MICRORNA 206; MICRORNA 21; MICRORNA 7; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG; WAY 200070; CHLORIDE; CYTOCHROME C OXIDASE; ESTROGEN; GINSENOSIDE; GINSENOSIDE 20S-PROTOPANAXATRIOL; NEUROPROSTANE; OXAZOLE DERIVATIVE; PHENOL DERIVATIVE; SAPOGENIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE POTENTIAL; CELL SURVIVAL; DEGENERATIVE DISEASE; DOWN REGULATION; DRUG EFFICACY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOTONEURON; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD INJURY; UPREGULATION; AGONISTS; ANIMAL; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MAMMALIAN EMBRYO; MEMBRANE POTENTIAL; METABOLISM; RAT; SPINAL CORD;

ANIMALS; APOPTOSIS; CELL LINE; CHLORIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT COMPLEX IV; EMBRYO, MAMMALIAN; ESTROGENS; GENE EXPRESSION REGULATION; GINSENOSIDES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE POTENTIALS; MICRORNAS; MOTOR NEURONS; NEUROPROSTANES; OXAZOLES; PHENOLS; RATS; RECEPTORS, ESTROGEN; SAPOGENINS; SPINAL CORD;

EID: 84888081707     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.10.027     Document Type: Article

References (43)

1. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J., Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 1997, 51:535-541.
2. Breving K., Esquela-Kerscher A. The complexities of miR regulation: mirandering around the rules. Int J Biochem Cell Biol 2010, 42:1316-1329.
3. Caron-Leslie L.A., Evans R.B., Cidlowski J.A. Bcl-2 inhibits glucocorticoid-induced apoptosis but only partially blocks calcium ionophore or cycloheximide-regulated apoptosis in S49 cells. FASEB J 1994, 8:639-645.
4. Chakrabarti M., Banik N.L., Ray S.K. Sequential hTERT knockdown and apigenin treatment inhibited invasion and proliferation and induced apoptosis in human malignant neuroblastoma SK-N-DZ and SK-N-BE2 cells. J Mol Neurosci 2013, 51:187-198.
5. Chakrabarti M., Khandkar M., Banik N.L., Ray S.K. Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells. Brain Res 2012, 1454:1-13.
6. Cordey M., Pike C.J. Neuroprotective properties of selective estrogen receptor agonists in cultured neurons. Brain Res 2005, 1045:217-223.
7. Crawford G.D., Le W.D., Smith R.G., Xie W.J., Appel S.H. A novel N18TG2! mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J Neurosci 1992, 12:3392-3398.
8. Das A., Banik N.L., Ray S.K. Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes. Cancer 2010, 116:164-176.
9. Das A., McDowell M., Pava M.J., Smith J.A., Reiter R.J., Woodward J.J., Varma A.K., Ray S.K., Banik N.L. The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-α toxicity involves membrane melatonin receptors. J Pineal Res 2010, 48:157-169.
10. Das A., Smith J.A., Gibson C., Varma A.K., Ray S.K., Banik N.L. Estrogen receptor agonists and estrogen attenuate TNF-α-induced apoptosis in VSC4.1 motoneurons. J Endocrinol 2011, 208:171-182.
11. 2+/calmodulin as well as cAMP-dependent protein kinase. Proc Natl Acad Sci U S A 1991, 88:5061-5065.
12. Eacker S.M., Dawson T.M., Dawson V.L. Understanding microRNAs in neurodegeneration. Nat Rev Neurosci 2009, 10:837-841.
13. Gerstner B., Lee J., DeSilva T.M., Jensen F.E., Volpe J.J., Rosenberg P.A. 17β-Estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain. J Neurosci Res 2009, 87:2078-2086.
14. Gonzalez A., Montminy M.R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 1989, 59:675-680.
15. Grau J.W., Crown E.D., Ferguson A.R., Washburn S.N., Hook M.A., Miranda R.C. Instrumental learning within the spinal cord: underlying mechanisms and implications for recovery after injury. Behav Cogn Neurosci Rev 2006, 5:191-239.
16. Grau J.W., Washburn S.N., Hook M.A., Ferguson A.R., Crown E.D., Garcia G., Bolding K.A., Miranda R.C. Uncontrollable stimulation undermines recovery after spinal cord injury. J Neurotraum 2004, 21:1795-1817.
17. Green P.S., Simpkins J.W. Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease. Ann N Y Acad Sci 2000, 924:93-98.
18. Hook M.A., Moreno G., Woller S., Puga D., Hoy K., Balden R., Grau J.W. Intrathecal morphine attenuates recovery of function after a spinal cord injury. J Neurotraum 2009, 26:741-752.
19. Knowles R.G., Moncada S. Nitric oxide as a signal in blood vessels. Trends Biochem Sci 1992, 17:399-402.
20. Kusuda R., Cadetti F., Ravanelli M.I., Sousa T.A., Zanon S., De Lucca F.L., Lucas G. Differential expression of microRNAs in mouse pain models. Mol Pain 2011, 7:7-17.
21. Lee G.Q., Yun Y., Hoeffler J.P., Habener J.F. Cyclic AMP responsive transcriptional activation of CREB-327 involves interdependent phosphorylated subdomains. EMBO J 1990, 9:4455-4465.
22. Li L.C., Okino S.T., Zhao H., Pookot D., Place R.F., Urakami S., Enokida H., Dahiya R. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A 2006, 103:17337-17342.
23. Liu N.K., Xu X.M. MicroRNA in central nervous system trauma and degenerative disorders. Physiol Genomics 2011, 43:571-580.
24. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
25. 2+ on GABA-activated currents in cerebellar granule cells in culture. J Membr Biol 1994, 142:209-216.
26. Nilsen J., Brinton R.D. Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disord 2004, 3:297-313.
27. Ray S.K., Hogan E.L., Banik N.L. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Rev 2003, 42:169-185.
28. Ray S.K., Samantaray S., Smith J.A., Matzelle D.D., Das A., Banik N.L. Inhibition of cysteine proteases in acute and chronic spinal cord injury. Neurotherapeutics 2011, 8:180-186.
29. Reed P.W., Lardy H.A. A23187: a divalent cation ionophore. J Biol Chem 1972, 247:6970-6977.
30. Rodriguez-Tarduchy G., Collins M., López-Rivas A. Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J 1990, 9:2997-3002.
31. Saugstad J.A. MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration. J Cereb Blood Flow Metab 2010, 30:1564-1576.
32. Sheng M., Thompson M.A., Greenberg M.E. CREB: a Ca-regulated transcription factor phosphorylated by calmodulin- dependent kinases. Science 1991, 252:1427-1430.
33. Smith R.G., Alexianu M.E., Crawford G., Nyormoi O., Stefani E., Appel S.H. Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc Natl Acad Sci U S A 1994, 91:3393-3397.
34. Soldatov N.M. Molecular determinants of Cav1.2 calcium channel inactivation. ISRN Mol Biol 2012, Article ID 691341. 10 pages.
35. Sribnick E.A., Ray S.K., Nowak M.W., Li L., Banik N.L. 17β-Estradiol attenuates glutamate-induced apoptosis and preserves electrophysiologic function in primary cortical neurons. J Neurosci Res 2004, 76:688-696.
36. Sribnick E.A., Wingrave J.M., Matzelle D.D., Wilford G.G., Ray S.K., Banik N.L. Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J Neurosci Res 2005, 82:283-293.
37. Sribnick E.A., Wingrave J.M., Matzelle D.D., Ray S.K., Banik N.L. Estrogen as a neuroprotective agent in the treatment of spinal cord injury. Ann N Y Acad Sci 2003, 993:125-133.
38. Sur P., Sribnick E.A., Wingrave J.M., Nowak M.W., Ray S.K., Banik N.L. Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells. Brain Res 2003, 971:178-188.
39. Wang X., Sada K., Yanagi S., Yang C., Rezaul K., Yamamura H. Intracellular calcium dependent activation of p72syk in platelets. J Biochem 1994, 116:858-861.
40. 2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and Bcl-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 2005, 135:59-72.
41. Yan H., Hong P., Jiang M., Li H. MicroRNAs as potential therapeutics for treating spinal cord injury. Neural Regen Res 2012, 7:1352-1359.
42. Yune T.Y., Park H.G., Lee J.Y., Oh T.H. Estrogen-induced Bcl-2 expression after spinal cord injury is mediated through phosphoinositide-3-kinase/Akt-dependent CREB activation. J Neurotraum 2008, 25:1121-1131.
43. 2+ rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: a potential initiation mechanism for estrogen neurotrophism. Neuroscience 2005, 132:299-311.